» Articles » PMID: 33101461

Survival of Recombinant Monoclonal and Naturally-occurring Human Milk Immunoglobulins A and G Specific to Respiratory Syncytial Virus F Protein Across Simulated Human Infant Gastrointestinal Digestion

Overview
Journal J Funct Foods
Publisher Elsevier
Date 2020 Oct 26
PMID 33101461
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

To help rationally design an antibody for oral administration, we examined how different isotypes (IgG, IgA and sIgA) with the same variable sequence affect antibody stability across digestion. We compared the degradation of recombinant palivizumab (IgG1), and recombinant IgA and sIgA versions of palivizumab spiked in human milk to the degradation of naturally-occurring anti-respiratory syncytial virus (RSV) sIgA/IgA and IgG in human milk from four donors across gastric and intestinal phases of an model of infant digestion via a validated RSV F protein ELISA. Palivizumab IgG and IgA formats were less stable than the sIgA version after complete simulated gastrointestinal digestion: palivizumab IgG, IgA and sIgA decreased across complete simulated gastrointestinal digestion by 55%, 48% and 28%, respectively. Naturally-occurring RSV F protein-specific IgG was stable across digestion, whereas naturally-occurring sIgA/IgA was stable in the gastric phase but decreased 33% in the intestinal phase of simulated digestion.

Citing Articles

Complementary measurement of nontyphoidal specific IgG and IgA antibodies in oral fluid and serum.

Elias S, Muthumbi E, Mwanzu A, Wanjiku P, Mutiso A, Simon R Heliyon. 2023; 9(1):e12071.

PMID: 36704288 PMC: 9871079. DOI: 10.1016/j.heliyon.2022.e12071.


Survival of Vaccine-Induced Human Milk SARS-CoV-2 IgG, IgA and SIgA Immunoglobulins across Simulated Human Infant Gastrointestinal Digestion.

Pieri M, Maniori M, Shahabian L, Kanaan E, Paphiti-Demetriou I, Pipis S Nutrients. 2022; 14(16).

PMID: 36014873 PMC: 9415426. DOI: 10.3390/nu14163368.

References
1.
Reilly R, Domingo R, Sandhu J . Oral delivery of antibodies. Future pharmacokinetic trends. Clin Pharmacokinet. 1997; 32(4):313-23. DOI: 10.2165/00003088-199732040-00004. View

2.
Roos N, Mahe S, Benamouzig R, SICK H, Rautureau J, Tome D . 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. J Nutr. 1995; 125(5):1238-44. DOI: 10.1093/jn/125.5.1238. View

3.
Munoz F, Piedra P, Glezen W . Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine. 2003; 21(24):3465-7. DOI: 10.1016/s0264-410x(03)00352-9. View

4.
Stensballe L, Ravn H, Kristensen K, Meakins T, Aaby P, Simoes E . Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus. J Pediatr. 2009; 154(2):296-8. DOI: 10.1016/j.jpeds.2008.07.053. View

5.
Stoll B, Lee F, Hale E, Schwartz D, Holmes R, Ashby R . Immunoglobulin secretion by the normal and the infected newborn infant. J Pediatr. 1993; 122(5 Pt 1):780-6. DOI: 10.1016/s0022-3476(06)80026-0. View